European Council for
Cardiovascular Research

Covid-19 and kidney disease

Fu et al. COVID-19 Infection in a Patient with End-Stage Kidney Disease. Nephron. 2020 Mar 27:1-3. doi: 10.1159/000507261. https://www.ncbi.nlm.nih.gov/pubmed/32222703

Choi et al. Renal replacement therapy is independently associated with a lower risk of death in patients with severe acute kidney injury treated with targeted temperature management after out-of-hospital cardiac arrest. Crit Care. 2020 Mar 23;24(1):115. doi: 10.1186/s13054-020-2822-x.https://www.ncbi.nlm.nih.gov/pubmed/32204725

Perico et al. Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade. Nephron. 2020 Mar 23:1-9. doi: 10.1159/000507305. https://www.ncbi.nlm.nih.gov/pubmed/32203970

Zhan et al. The potential risk of kidney vulnerable to novel coronavirus 2019 infection. Am J Physiol Renal Physiol. 2020 Mar 30. doi: 10.1152/ajprenal.00085.2020. https://www.ncbi.nlm.nih.gov/pubmed/32223555

Cheng et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020 Mar 20. pii: S0085-2538(20)30255-6. doi: 10.1016/j.kint.2020.03.005. https://www.ncbi.nlm.nih.gov/pubmed/32247631

Henry et al. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection. Int Urol Nephrol. 2020 Mar 28. doi: 10.1007/s11255-020-02451-9. https://www.ncbi.nlm.nih.gov/pubmed/32222883